-
Je něco špatně v tomto záznamu ?
The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study)
W. Wojciechowska, M. Rajzer, R. Kreutz, T. Weber, M. Bursztyn, A. Persu, G. Stergiou, G. Parati, G. Bilo, A. Pac, G. Grassi, G. Mancia, A. Januszewicz, M. Chrostowska, K. Narkiewicz, A. Dubiela, M. Doumas, K. Imprialos, K. Stavropoulos, JB. de...
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- ambulantní monitorování krevního tlaku * MeSH
- antihypertenziva * terapeutické užití MeSH
- COVID-19 * epidemiologie patofyziologie MeSH
- hypertenze * patofyziologie epidemiologie farmakoterapie MeSH
- krevní tlak * MeSH
- lidé středního věku MeSH
- lidé MeSH
- pandemie MeSH
- SARS-CoV-2 MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: We aimed to determine the influence of coronavirus disease 2019 (COVID-19) pandemic on blood pressure (BP) control assessed by ambulatory blood pressure monitoring (ABPM). METHODS: Office BP and ABPM data from two visits conducted within a 9-15 months interval were collected from patients treated for hypertension. In the prepandemic group, both visits took place before, while in the pandemic group, Visit-1 was done before and Visit-2 during the pandemic period. RESULTS: Of 1811 collected patients 191 were excluded because they did not meet the required ABPM time frames. Thus, the study comprised 704 patients from the pandemic and 916 from the prepandemic group. Groups did not differ in sex, age, duration of hypertension, frequency of first line antihypertensive drug use and mean 24 h BP on Visit-1. The prevalence of sustained uncontrolled hypertension was similar in both groups. On Visit-2 mean 24 h BP, daytime and nighttime systolic BP and diastolic BP were higher in the pandemic compared to the prepandemic group ( P < 0.034). The prevalence of sustained uncontrolled hypertension on Visit-2 was higher in the pandemic than in the prepandemic group [0.29 (95% confidence interval (95% CI): 0.26-0.33) vs. 0.25 (95% CI: 0.22-0.28), P < 0.037]. In multivariable adjusted analyses a significant difference in BP visit-to-visit change was observed, with a more profound decline in BP between visits in the prepandemic group. CONCLUSIONS: This study using ABPM indicates a negative impact of the COVID-19 pandemic on BP control. It emphasizes the need of developing strategies to maintain BP control during a pandemic such as the one induced by COVID-19.
2nd Prop Department of Internal Medicine Aristotle University Thessaloniki Greece
APHP Hôpital Européen Georges Pompidou Hypertension department F 75015 Paris France
Cardiology Department Klinikum Wels Grieskirchen Wels Austria
Center for Hypertension Charles University Prague Czech Republic
Clinica Medica Dept of Medicine and Surgery University of Milano Bicocca Milan Italy
Department of Cardiology Geneva University Hospitals Geneva Switzerland
Department of Cardiology S Luca Hospital IRCCS Istituto Auxologico Italiano Milan Italy
Department of Cardiology The Pope John Paul 2 Province Hospital of Zamość Zamość Poland
Department of Hypertension National Institute of Cardiology Warsaw Poland
Department of Internal Medicine and Hypertension Medical University of Bialystok Bialystok Poland
Department of Medicine and Surgery University of Milano Bicocca
Hospital Universitario de Badajoz Badajoz Spain
Hypertension and Diabetes Centre Grudziadz
Hypertension Clinic Department of Cardiology KAT General Hospital Athens Greece
Hypertension Clinic University Hospital Laiko Athens Greece
Internal Medicine and Geriatrics University Politecnica delle Marche and IRCCS INRCA Ancona Italy
MEDYK Medical Center in Rzeszów
National Institute of Cardiology Warsaw Poland
Université Paris Cité F75006 Paris France
Vascular Risk Unit Internal Medicine Virgen de las Nieves University Hospital Granada Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003277
- 003
- CZ-PrNML
- 005
- 20250206104222.0
- 007
- ta
- 008
- 250121s2024 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/HJH.0000000000003752 $2 doi
- 035 __
- $a (PubMed)39248094
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Wojciechowska, Wiktoria $u Jagiellonian University Medical College, 1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Krakow, Poland
- 245 14
- $a The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study) / $c W. Wojciechowska, M. Rajzer, R. Kreutz, T. Weber, M. Bursztyn, A. Persu, G. Stergiou, G. Parati, G. Bilo, A. Pac, G. Grassi, G. Mancia, A. Januszewicz, M. Chrostowska, K. Narkiewicz, A. Dubiela, M. Doumas, K. Imprialos, K. Stavropoulos, JB. de Freminville, M. Azizi, PG. Cunha, J. Lewandowski, J. Strzelczyk, G. Wuerzner, M. Gosk-Przybyłek, E. Szwench-Pietrasz, A. Prejbisz, P. Van der Niepen, T. Kahan, A. Jekell, J. Spaak, K. Tsioufis, G. Ehret, A. Doroszko, P. Kubalski, J. Polonia, K. Styczkiewicz, M. Styczkiewicz, S. Mazur, F. Veglio, F. Rabbia, E. Eula, FJ. Águila, R. Sarzani, F. Spannella, Z. Jarai, D. Papadopoulos, M. Lopez-Sublet, A. Ostrowska, C. Grassos, I. Kahrimanidis, G. Eugenia, T. Areti, G. Tomasz, W. Barbara, S. Aleksandra, M. Beata, N. Angeliki, NR. Robles, J. Widmiski, E. Zbroch, ESH ABPM COVID-19 Study Investigators (Excellence Centres of the European Society of Hypertension)
- 520 9_
- $a BACKGROUND: We aimed to determine the influence of coronavirus disease 2019 (COVID-19) pandemic on blood pressure (BP) control assessed by ambulatory blood pressure monitoring (ABPM). METHODS: Office BP and ABPM data from two visits conducted within a 9-15 months interval were collected from patients treated for hypertension. In the prepandemic group, both visits took place before, while in the pandemic group, Visit-1 was done before and Visit-2 during the pandemic period. RESULTS: Of 1811 collected patients 191 were excluded because they did not meet the required ABPM time frames. Thus, the study comprised 704 patients from the pandemic and 916 from the prepandemic group. Groups did not differ in sex, age, duration of hypertension, frequency of first line antihypertensive drug use and mean 24 h BP on Visit-1. The prevalence of sustained uncontrolled hypertension was similar in both groups. On Visit-2 mean 24 h BP, daytime and nighttime systolic BP and diastolic BP were higher in the pandemic compared to the prepandemic group ( P < 0.034). The prevalence of sustained uncontrolled hypertension on Visit-2 was higher in the pandemic than in the prepandemic group [0.29 (95% confidence interval (95% CI): 0.26-0.33) vs. 0.25 (95% CI: 0.22-0.28), P < 0.037]. In multivariable adjusted analyses a significant difference in BP visit-to-visit change was observed, with a more profound decline in BP between visits in the prepandemic group. CONCLUSIONS: This study using ABPM indicates a negative impact of the COVID-19 pandemic on BP control. It emphasizes the need of developing strategies to maintain BP control during a pandemic such as the one induced by COVID-19.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a COVID-19 $x epidemiologie $x patofyziologie $7 D000086382
- 650 12
- $a hypertenze $x patofyziologie $x epidemiologie $x farmakoterapie $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a ambulantní monitorování krevního tlaku $7 D018660
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a krevní tlak $7 D001794
- 650 12
- $a antihypertenziva $x terapeutické užití $7 D000959
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a pandemie $7 D058873
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rajzer, Marek $u Jagiellonian University Medical College, 1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Krakow, Poland
- 700 1_
- $a Kreutz, Reinhold $u Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany
- 700 1_
- $a Weber, Thomas $u Cardiology Department Klinikum Wels-Grieskirchen, Wels, Austria
- 700 1_
- $a Bursztyn, Michael $u Faculty of Medicine, Hadassah-Hebrew University Jerusalem, Hadassah-Hebrew University Medical Center Mount-Scopus, Jerusalem, Israel
- 700 1_
- $a Persu, Alexandre $u Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
- 700 1_
- $a Stergiou, George $u Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
- 700 1_
- $a Parati, Gianfranco $u Department of Medicine and Surgery, University of Milano-Bicocca $u Department of Cardiology, S. Luca Hospital, IRCCS, Istituto Auxologico Italiano, Milan, Italy
- 700 1_
- $a Bilo, Grzegorz $u Department of Medicine and Surgery, University of Milano-Bicocca $u Department of Cardiology, S. Luca Hospital, IRCCS, Istituto Auxologico Italiano, Milan, Italy
- 700 1_
- $a Pac, Agnieszka $u Department of Epidemiology, Chair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Krakow, Poland
- 700 1_
- $a Grassi, Guido $u Clinica Medica, Dept of Medicine and Surgery, University of Milano Bicocca, Milan Italy
- 700 1_
- $a Mancia, Giuseppe $u Department of Medicine and Surgery, University of Milano-Bicocca
- 700 1_
- $a Januszewicz, Andrzej $u Department of Hypertension, National Institute of Cardiology, Warsaw, Poland
- 700 1_
- $a Chrostowska, Marzena $u Hypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland
- 700 1_
- $a Narkiewicz, Krzysztof $u Hypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland
- 700 1_
- $a Dubiela, Andżelina $u Hypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland
- 700 1_
- $a Doumas, Michaelis $u 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece
- 700 1_
- $a Imprialos, Konstantinos $u 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece
- 700 1_
- $a Stavropoulos, Konstantinos $u 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece
- 700 1_
- $a de Freminville, Jean-Baptiste $u Université Paris Cité, F75006, Paris, France; APHP, Hôpital Européen Georges Pompidou, Hypertension department, F-75015, Paris, France
- 700 1_
- $a Azizi, Michel $u Université Paris Cité, F75006, Paris, France; APHP, Hôpital Européen Georges Pompidou, Hypertension department, F-75015, Paris, France
- 700 1_
- $a Cunha, Pedro Guimarães $u Centre for the Research and Treatment of Arterial Hypertension, Guimarães, Portugal, Minho Medical School, Minho University, Portugal
- 700 1_
- $a Lewandowski, Jacek $u Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Strzelczyk, Jakub $u Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Wuerzner, Gregoire $u Hypertension Centre of the Lausanne University Hospital, Service of Nephrology and Hypertension, Lausanne, Switzerland
- 700 1_
- $a Gosk-Przybyłek, Maria $u National Institute of Cardiology, Warsaw, Poland
- 700 1_
- $a Szwench-Pietrasz, Elżbieta $u National Institute of Cardiology, Warsaw, Poland
- 700 1_
- $a Prejbisz, Aleksander $u National Institute of Cardiology, Warsaw, Poland
- 700 1_
- $a Van der Niepen, Patricia $u Department of Nephrology and Hypertension, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
- 700 1_
- $a Kahan, Thomas $u Cardiovascular Risk Assessment Unit, Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden
- 700 1_
- $a Jekell, Andreas $u Cardiovascular Risk Assessment Unit, Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden
- 700 1_
- $a Spaak, Jonas $u Cardiovascular Risk Assessment Unit, Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden
- 700 1_
- $a Tsioufis, Konstantinos $u First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece
- 700 1_
- $a Ehret, Georg $u Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland
- 700 1_
- $a Doroszko, Adrian $u Clinical Department of Internal Diseases, Hypertension and Clinical Oncology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
- 700 1_
- $a Kubalski, Piotr $u Hypertension and Diabetes Centre, Grudziadz
- 700 1_
- $a Polonia, Jorge $u Faculty of Medicine, University of Porto, & Hypertension, HTA and Cardiovascular Risk Unit, ULS Matosinhos, Matosinhos, Portugal
- 700 1_
- $a Styczkiewicz, Katarzyna $u Department of Internal Medicine, Institute of Medical Sciences, Medical College, University of Rzeszów, Poland
- 700 1_
- $a Styczkiewicz, Marek $u Department of Cardiology, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland
- 700 1_
- $a Mazur, Stanisław $u MEDYK Medical Center in Rzeszów
- 700 1_
- $a Veglio, Franco $u Hypertension Unit, Division of Internal Medicine, Department of Medical Sciences, AO 'Città della Salute e della Scienza' University Hospital, Turin, Italy
- 700 1_
- $a Rabbia, Franco $u Hypertension Unit, Division of Internal Medicine, Department of Medical Sciences, AO 'Città della Salute e della Scienza' University Hospital, Turin, Italy
- 700 1_
- $a Eula, Elisabetta $u Hypertension Unit, Division of Internal Medicine, Department of Medical Sciences, AO 'Città della Salute e della Scienza' University Hospital, Turin, Italy
- 700 1_
- $a Águila, Fernando Jaen $u Vascular Risk Unit. Internal Medicine. Virgen de las Nieves University Hospital. Granada. Spain
- 700 1_
- $a Sarzani, Riccardo $u Internal Medicine and Geriatrics, University Politecnica delle Marche, and IRCCS INRCA, Ancona, Italy
- 700 1_
- $a Spannella, Francesco $u Internal Medicine and Geriatrics, University Politecnica delle Marche, and IRCCS INRCA, Ancona, Italy
- 700 1_
- $a Jarai, Zoltan $u Department of Cardiology, South-Buda Center Hospital - St Imre University Teaching Hospital, Budapest, Hungary
- 700 1_
- $a Papadopoulos, Dimitrios $u Hypertension Clinic, University Hospital Laiko, Athens, Greece
- 700 1_
- $a Lopez-Sublet, Marilucy $u AP-HP, Hôpital Avicenne, Centre d'Excellence Européen en Hypertension Artérielle, Service de Médecine Interne, Bobigny, France. INSERM UMR 942 MASCOT, Paris 13-Université Paris Nord. FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France
- 700 1_
- $a Ostrowska, Aleksandra $u First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University, Medical College, Krakow, Poland
- 700 1_
- $a Grassos, Charalampos $u Hypertension Clinic, Department of Cardiology, KAT General Hospital, Athens, Greece
- 700 1_
- $a Kahrimanidis, Ioannis $u Hypertension Clinic, Department of Cardiology, KAT General Hospital, Athens, Greece
- 700 1_
- $a Eugenia, Gkaliagkousi $u Third Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
- 700 1_
- $a Areti, Triantafyllou $u Third Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
- 700 1_
- $a Tomasz, Grodzicki $u Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland
- 700 1_
- $a Barbara, Wizner $u Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland
- 700 1_
- $a Aleksandra, Seweryn $u Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland
- 700 1_
- $a Beata, Moczulska $u Department of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
- 700 1_
- $a Angeliki, Ntineri $u Hypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Greece
- 700 1_
- $a Robles, Nicolas Roberto $u Hospital Universitario de Badajoz, Badajoz, Spain
- 700 1_
- $a Widmiski, Jiri $u Center for Hypertension, Charles University, Prague, Czech Republic
- 700 1_
- $a Zbroch, Edyta $u Department of Internal Medicine and Hypertension, Medical University of Bialystok, Bialystok, Poland
- 710 2_
- $a ESH ABPM COVID-19 Study Investigators (Excellence Centres of the European Society of Hypertension)
- 773 0_
- $w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 42, č. 12 (2024), s. 2065-2074
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39248094 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104217 $b ABA008
- 999 __
- $a ok $b bmc $g 2263183 $s 1239284
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 42 $c 12 $d 2065-2074 $e 20240919 $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
- LZP __
- $a Pubmed-20250121
